These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 12220882)

  • 1. Axon pathology in neurological disease: a neglected therapeutic target.
    Coleman MP; Perry VH
    Trends Neurosci; 2002 Oct; 25(10):532-7. PubMed ID: 12220882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Programmed axon death, synaptic dysfunction and the ubiquitin proteasome system.
    Coleman MP; Ribchester RR
    Curr Drug Targets CNS Neurol Disord; 2004 Jun; 3(3):227-38. PubMed ID: 15180483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The slow Wallerian degeneration gene, WldS, inhibits axonal spheroid pathology in gracile axonal dystrophy mice.
    Mi W; Beirowski B; Gillingwater TH; Adalbert R; Wagner D; Grumme D; Osaka H; Conforti L; Arnhold S; Addicks K; Wada K; Ribchester RR; Coleman MP
    Brain; 2005 Feb; 128(Pt 2):405-16. PubMed ID: 15644421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deconstructing the axon: Wallerian degeneration and the ubiquitin-proteasome system.
    Ehlers MD
    Trends Neurosci; 2004 Jan; 27(1):3-6. PubMed ID: 14698600
    [No Abstract]   [Full Text] [Related]  

  • 5. Involvement of the ubiquitin-proteasome system in the early stages of wallerian degeneration.
    Zhai Q; Wang J; Kim A; Liu Q; Watts R; Hoopfer E; Mitchison T; Luo L; He Z
    Neuron; 2003 Jul; 39(2):217-25. PubMed ID: 12873380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The ubiquitin proteasome system in synaptic and axonal degeneration: a new twist to an old cycle.
    Korhonen L; Lindholm D
    J Cell Biol; 2004 Apr; 165(1):27-30. PubMed ID: 15067020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Axon degeneration: molecular mechanisms of a self-destruction pathway.
    Wang JT; Medress ZA; Barres BA
    J Cell Biol; 2012 Jan; 196(1):7-18. PubMed ID: 22232700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroprotective strategies in MS: lessons from C57BL/Wld(S) mice.
    Coleman MP; Adalbert R; Beirowski B
    J Neurol Sci; 2005 Jun; 233(1-2):133-8. PubMed ID: 15899498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TMEM184b Promotes Axon Degeneration and Neuromuscular Junction Maintenance.
    Bhattacharya MR; Geisler S; Pittman SK; Doan RA; Weihl CC; Milbrandt J; DiAntonio A
    J Neurosci; 2016 Apr; 36(17):4681-9. PubMed ID: 27122027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Axon pruning during Drosophila metamorphosis: evidence for local degeneration and requirement of the ubiquitin-proteasome system.
    Watts RJ; Hoopfer ED; Luo L
    Neuron; 2003 Jun; 38(6):871-85. PubMed ID: 12818174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Axon degeneration: Mechanisms and implications of a distinct program from cell death.
    Yan T; Feng Y; Zhai Q
    Neurochem Int; 2010 Mar; 56(4):529-34. PubMed ID: 20117162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship of acute axonal damage, Wallerian degeneration, and clinical disability in multiple sclerosis.
    Singh S; Dallenga T; Winkler A; Roemer S; Maruschak B; Siebert H; Brück W; Stadelmann C
    J Neuroinflammation; 2017 Mar; 14(1):57. PubMed ID: 28302146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Wld(S) mutation delays anterograde, but not retrograde, axonal degeneration of the dopaminergic nigro-striatal pathway in vivo.
    Cheng HC; Burke RE
    J Neurochem; 2010 May; 113(3):683-91. PubMed ID: 20132467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Wld(S), Nmnats and axon degeneration--progress in the past two decades.
    Feng Y; Yan T; He Z; Zhai Q
    Protein Cell; 2010 Mar; 1(3):237-45. PubMed ID: 21203970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular mechanisms of neurodegeneration in Parkinson's disease: clues from Mendelian syndromes.
    Lim KL; Lim TM
    IUBMB Life; 2003 Jun; 55(6):315-22. PubMed ID: 12938733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurological disease: UPS stops delivering!
    Miller RJ; Wilson SM
    Trends Pharmacol Sci; 2003 Jan; 24(1):18-23. PubMed ID: 12498726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genotyping methods to detect a unique neuroprotective factor (Wld(s)) for axons.
    Mi W; Conforti L; Coleman MP
    J Neurosci Methods; 2002 Jan; 113(2):215-8. PubMed ID: 11772443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synaptic plasticity: importance of proteasome-mediated protein turnover.
    Cline H
    Curr Biol; 2003 Jul; 13(13):R514-6. PubMed ID: 12842027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of axonal spheroid formation in central nervous system Wallerian degeneration.
    Beirowski B; Nógrádi A; Babetto E; Garcia-Alias G; Coleman MP
    J Neuropathol Exp Neurol; 2010 May; 69(5):455-72. PubMed ID: 20418780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of Wld(S) or Nmnat2 in mauthner cells by single-cell electroporation delays axon degeneration in live zebrafish.
    Feng Y; Yan T; Zheng J; Ge X; Mu Y; Zhang Y; Wu D; Du JL; Zhai Q
    J Neurosci Res; 2010 Nov; 88(15):3319-27. PubMed ID: 20857515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.